CL en false false Default
Skip directly to Accessibility Notice

Beyond the U.S.: A Smarter Approach to International and EM Investing

Webinar details

September 29, 2026

11:00 US ET

Duration 30 MIN

U.S. equity concentration is near historic highs. International and emerging markets equities are gaining ground after years of U.S. dominance. EM is offering higher earnings growth at a significant valuation discount to U.S. peers. If you haven’t revisited your international and emerging markets allocation recently, now is the time.

VEEM and VEFA use a rules-based analyst sentiment signal to systematically identify companies with improving fundamentals before the broader market prices it in.

  • The case for international and EM equities as the post-U.S.-dominance cycle takes hold
  • How the analyst sentiment signal identifies companies with improving fundamentals
  • How VEEM and VEFA can complement or replace a traditional broad international or emerging markets allocation

An on demand replay will be available immediately after the live webinar.

Important Disclosures

This is not an offer to buy or sell, or a recommendation to buy or sell any of the securities, financial instruments or digital assets mentioned herein. The information presented does not involve the rendering of personalized investment, financial, legal, tax advice, or any call to action. Certain statements contained herein may constitute projections, forecasts and other forward-looking statements, which do not reflect actual results, are for illustrative purposes only, are valid as of the date of this communication, and are subject to change without notice. Actual future performance of any assets or industries mentioned are unknown. Information provided by third party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. VanEck does not guarantee the accuracy of third party data. The information herein represents the opinion of the author(s), but not necessarily those of VanEck or its other employees.

MSCI EAFE Index: The MSCI EAFE Index is an equity index which captures large and mid cap representation across 21 Developed Markets countries around the world, excluding the US and Canada. With 694 constituents, the index covers approximately 85% of the free float-adjusted market capitalization in each country.

MSCI EAFE Analyst Sentiment Select Index: MSCI EAFE Analyst Sentiment Select Index is based on MSCI EAFE Index, its parent index which includes large and mid-cap stocks across 21 Developed Markets countries around the world, excluding the US and Canada. The index uses an optimization process that aims to maximize the exposure to the Analyst Sentiment factor, while controlling for active risk, active specific risk and net ex-ante beta relative to the parent index.

MSCI Emerging Markets Analyst Sentiment Select Index: The MSCI Emerging Markets Analyst Sentiment Select Index is based on the MSCI Emerging Markets Index, its parent index, which captures large and mid-cap representation across Emerging Markets countries. The index uses an optimization process that aims to maximize the exposure to the Analyst Sentiment factor, while controlling for active risk, active specific risk and net ex-ante beta relative to the parent index.

Index returns are not Fund returns and do not reflect any management fees or brokerage expenses. Certain indices may take into account withholding taxes. Investors can not invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses. Index returns assume that dividends have been reinvested.

An investment in the VanEck MSCI EM Analyst Sentiment ETF (VEEM) and VanEck MSCI EAFE Analyst Sentiment ETF (VEFA) may be subject to risks which include, but are not limited to, risks related to investments in emerging market issuers, foreign securities, foreign currency, information technology sector, financials sector, basic materials sector, industrials sector, health care sector, special risk considerations of investing in Chinese, European, Indian, Japanese, South Korean, Taiwanese and United Kingdom issuers, cash transactions, depositary receipts, equity securities, issuer-specific changes, medium- and large-capitalization companies, market, operational, index tracking, authorized participant concentration, new fund, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount, liquidity of fund shares, non-diversified, and index-related concentration risks, all of which may adversely affect the Funds. Emerging market issuers and foreign securities may be subject to securities markets, political and economic, investment and repatriation restrictions, different rules and regulations, less publicly available financial information, foreign currency and exchange rates, operational and settlement, and corporate and securities laws risks. Investments in Chinese issuers may entail additional risks that include, among others, lack of liquidity and price volatility, currency devaluations and exchange rate fluctuations, intervention by the Chinese government, nationalization or expropriation, limitations on the use of brokers, and trade limitations. Medium- and large-capitalization companies may be subject to elevated risks.

Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of a Fund carefully before investing. To obtain a prospectus and summary prospectus, which contain this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.

© Van Eck Securities Corporation, Distributor, a wholly owned subsidiary of Van Eck Associates Corporation.